Ending months of uncertainty, French pharma major Sanofi-aventis said on Wednesday it will buy US biotechnology giant Genzyme Corp for more than $20 billion.The proposed deal has been dragging due......
Glenmark Pharmaceuticals on Monday said its subsidiary Glenmark Pharmaceuticals SA has granted licence to Sanofi-aventis for developing drugs to treat chronic pain, for an initial payment of $20......
Sanofi-aventis on Mondaysaid it has extended its $18.5 billion offer for Genzyme for the second time, a move that will give the French drug-maker additional time to reach an agreement with US......
Aventis Pharma, the Indian arm of sanofi-aventis, the world's third largest drug company, is planning to ramp up its domestic operations with acquisition of brands and make India a major hub for......
A Union health ministry probe has revealed that pharmaceutical majors conducting clinical trials in India have not given compensation to majority of the volunteers who died during the trials.Of the......